The metabolomics is currently an up-growing ‘OMICS’ approach, for therapeutic interventions, where this technology is being increasingly adopted for biomarker discovery, in tandem with genomics, for better understating of underlying causes of pathology. The present status of metabolomics promises healthy growth opportunities in biomarkers and genomics- based research. As several companies and universities are focusing on the research related to early and better diagnosis of a diseases, as well as improved treatment option, the metabolic pathways are well- explored at the academic and a biopharmaceutical R&D level.

1. INTRODUCTION

2. RESEARCH METHODOLOGY 

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

5. MARKET SEGMENTATION

6. COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS